Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds Vivasgastroenterology-hepatology-and-nutrition

Paeds Vivas · gastroenterology-hepatology-and-nutrition

Gastro-oesophageal reflux and reflux disease — structured oral (viva)

Branching structured oral on an unsettled thriving infant with posseting, testing the distinction between physiologic reflux and disease, the conservative-first ladder, exclusion of cow's milk protein allergy, and the evidence against acid suppression.

branching clinical structured oral
On this page & tools

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
A 4-month-old thriving formula-fed infant is brought by parents distressed by frequent effortless posseting, crying, and back-arching after feeds. There is no bilious or bloody vomiting and no faltering growth. The general practitioner has already prescribed a proton-pump inhibitor with no improvement, and the parents want to know what to do next.

Branch 1 — Definition and classification

Examiner: "Is this reflux or GORD, and what separates the two?" Candidate: This is physiologic gastro-oesophageal reflux. GOR is the effortless retrograde passage of gastric contents into the oesophagus, and in infants it is a normal, self-limiting developmental phenomenon. GORD is reserved for reflux that causes troublesome symptoms or complications — faltering growth, oesophagitis, haematemesis, recurrent aspiration, or distress impairing quality of life. This infant is thriving with effortless posseting and no red flags, so this is physiologic reflux, not disease. [1]

Examiner: "What red flags would change your mind?" Candidate: I would reconsider with bilious or green vomiting, forceful or projectile vomiting, faltering growth, haematemesis or anaemia, or recurrent aspiration. Late onset after six months or persistence beyond the first birthday would also make me look for another diagnosis. Bilious vomiting is the cardinal danger sign — it signals intestinal obstruction, most dangerously malrotation with volvulus, and it needs urgent contrast imaging and surgical review, not anti-reflux therapy. [1]

Branch 2 — Management and the failed PPI

Examiner: "The proton-pump inhibitor has not helped. What will you do?" Candidate: I would stop the proton-pump inhibitor, because it is not indicated and its failure to help is expected. The first step is reassurance that reflux is normal and self-limiting. I would optimise feeding with smaller, more frequent volumes, avoid overfeeding, and use upright positioning and careful winding. As this is a formula-fed infant with crying and arching, I would trial an extensively hydrolysed formula for two to four weeks to exclude cow's milk protein allergy, and if symptoms remained troublesome I would trial an alginate, the drug with the best short-term evidence in infants. [1]

Branch 3 — Excluding the mimics

Examiner: "What are you most worried about missing?" Candidate: Cow's milk protein allergy is the mimic I would actively exclude, given the crying and arching, and it responds to a hydrolysed formula trial. I would also make sure I have not missed a surgical cause such as malrotation in any bilious vomiter, pyloric stenosis in a projectile vomiter, or a systemic cause such as urinary tract infection or raised intracranial pressure. In an older child with dysphagia or food impaction I would consider eosinophilic oesophagitis, which needs endoscopy and biopsy rather than acid suppression. [1]

Branch 4 — Evidence and prescribing

Examiner: "What is the evidence against acid suppression here, and what about prokinetics?" Candidate: A large placebo-controlled trial of lansoprazole in symptomatic infants found no benefit over placebo and more lower respiratory infections in the treated group, so proton-pump inhibitors are not indicated for infant crying, arching, or physiologic reflux, and an empirical trial is not a valid diagnostic test. Prokinetics such as domperidone are not recommended for routine use because their efficacy is weak and they carry a risk of QT prolongation and cardiac arrhythmia. The safest and most effective interventions here are reassurance, feeding optimisation, and exclusion of cow's milk protein allergy. [2] [3]

References

  1. [1]Rosen R, Vandenplas Y, Singendonk M, et al Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr, 2018.PMID 29470322
  2. [2]Orenstein SR, Hassall E, Furmaga-Jablonska W, et al Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr, 2009.PMID 19054529
  3. [3]Puoti MG, Assa A, Benninga M, et al Drugs in Focus: Domperidone. J Pediatr Gastroenterol Nutr, 2023.PMID 37159421